ABSTRACT
Introduction
Sialyltransferases * (ST) exist as membrane linked and soluble enzymes and are involved in the biosynthesis of sialoglycoproteins by transfer of cytidine monophosphate -N-acetyl (4, 5, 6, 7, 8, (9) (10) (11) (12) (13) (14) C) neuraminic (sialic) acid (CMP-NANA) onto the newly synthesized glycoproteins and glycolipids. ST consist of large family of enzymes differing in their substrate specifity, the type of linkage of sialic acids (SAs) (α 2-3; α 2-6; α 2-8; α 2-9 etc.), tissue distribution and various biochemical parameters * Abbreviation: HIV-1 -human immunodeficiency virus -1; ST -sialyltransferase; CMP-NANAcytidine monophosphate -N-acetyl (4, 5, 6, 7, 8, (9) (10) (11) (12) (13) (14) C) neuraminic acid; SA -Sialic acid; Sgps -sialoglycoproteins; [ 14 C]NAcMan -N-Acetyl-D-[U-14 C]Mannosamine; CSs -cytosols; SNs -supernatants; p24Ag -protein 24 antigen; RT -reverse transcriptasе (11) . Formation of sialoglycoproteins (Sgps) is type specific and is catalyzed by specific ST which are key enzymes for the glycosylation process of the oligosaccharide chain of Sgps and glycolipids. The importance of these enzymes additionally is conferred by the fact that the SAs define the electronegative charge of the molecule. Sialylated oligosaccharides of glycoproteins and glycolipids have been implicated in many biological processes such as cell adhesion and receptor recognition (21) and SAs play an important role in the maintenance of serum glycoproteins in circulation, virus and microbial infections of host cells, malignant transformation, cell adhesion mediated by selectins and cell-cell interaction (1, 4, 7, 8, 16) . The structural diversity and regulated expression of sialoglycoconjugates appear to correlate with their functions (19, 15, 17) .
Earlier, by using a labeled precursor of SA biosynthesis we obtained highly purified and well characterized Sgp patterns of N-Acetyl-D-[U-14 C]Mannosamine ([ 14 C]NAcMan) HIV-1 from cytosols (CSs) and supernatants (SNs) of chronically and acutely HIV infected cells. It has been shown that labeled CSs were more convenient to be used in study of sialylation processes in experimental HIVinfections than the appropriate SNs because of higher incorporation combined with similarity of pI peaks distribution (10) .
So far no data about ST-activity in HIVinfected cells have been published in the literature. The aim of the current work was to detect ST-activity in CSs (membranelinked forms) and SNs (soluble forms) of chronically and acutely HIV infected cells and to look for some correlation between enzyme activity and the synthesis of specific Sgps.
Materials and Methods
Materials CMP-N-acetyl(4,5,6,7,8,9-14 C) neuraminic acid (CMP-NANA), specific activity 150-300 mCi/mmol, was obtained from Radiochemical Center, Amersham, England; Triton X-100, asialofetuin and unlabeled CMP-NANA were purchased from Sigma Chemical Co., St.Louis, USA.
Cells
The following cell lines were used: H9 uninfected and H9/HTLV III B -chronically infected with HIV-1 LAI cells, kindly provided by Prof. R. Gallo; MT-2 -uninfected human lymphoblastoid cells, HTLV-I transformed; MT-2/HIV-1 -MT-2 cells acutely infected with HIV-1. All cell lines were maintained in RPMI 1640 plus 10% FCS. MT-2 cells were infected with HIV-1 in suspension (37ºC/5%CO 2 ) and then grown parallely with uninfected ones. Virus As source of HIV-1 SNs of H9/HTLV III B cell line were used. The SNs were collected, centrifuged to remove the cells and virus stocks were prepared. Each stock was characterized by infectivity, protein 24 antigen (p24Ag) content and reverse transcriptase (RT)-activity. RT activity was measured and expressed as pgRT/ml by non-radioactive commercially available HS-kit Lenti-RT kit assay containing recombinant RT with known concentration (Cavidi, Sweden). P24Ag concentration was detected as pg/ml (Murex HIV Antigen Mab -VK86 -Murex, Germany).
CSs and SNs preparation
After centrifugation, SNs were removed; cells counted and the cell pellets chilled in ice water and then disrupted mechanically by Dounce homogenizer.
Sialyltransferase assay
For detection of ST activity the method described by Serafini-Cessi F., 1977 (22), was applied. The assay mixture contained the following components in a total volume of 100 µl: 30 µl asialofetuin; 25 µl 0,5M maleic acid, pH 6,5; 5 µl 10mM MnCl 2 ; 5 µl 0,1% Triton X-100 (used for cells, not for SNs); 5 µl 1,4 nmol labeled CMP-NANA; 2,5 µl 7,14 mM unlabeled CMP-NANA; 32,5 µl (700 µg protein) sample. The protein content was measured by the method of Bradford M., 1976 (3). The assay mixture was incubated at 37 ºC for 30 min in a Dubnoff shaker. The reaction was terminated by the addition of 1% phosphotungstic acid (PTA) in 0,5 HCl. The resultant pellet was filtered under suction through GF/A filters (Whatman, England) and washed with 50 ml PTA and 5 ml ethanol-ether. The dried discs were counted for radioactivity in a toluene based scintillation solution (4.0g PPO and 0,15g POPOP in 1 l toluene) using LKB scintillation counter. Statistical analysis. Variation analysis by Student-Fisher test was applied.
Results and Discussion
First, the CS levels of ST activity in uninfected H9 and chronically infected H9/HTLVIIIB cells were measured. The results showed (Table 1, Fig. 1 ) statistical- ly significant higher ST-activity in the CSs of chronically infected cells (expressed as 14C-NANA incorporation) compared to uninfected ones. As seen, ST-activity (nmolesSA/mg protein/1hr) was 1,8 times higher in the CSs of H9/HTLV III B compared to enzyme activity of uninfected ones. The same dependence was well documented when evaluating the incorporation rate of labeled NANA (pmolesSA/10 6 cells/hr) in asialofetuin for infected and uninfected cells. This corresponds well to our earlier findings detecting higher sialylation of H9/HTLV III B CSs (10).
Similar correlation was observed for the SNs of H9/HTLVIIIB and H9 cells (814 ± 80 and 572 ± 56 resp.) (Fig. 2) .
ST-activity under chronic infection confirms the assumption that the sialylation process seems to be virus-specific and more intensive in the infected H9/HTLVIIIB cells. Earlier a direct radioactive precursor of biosynthesis of SAs was used to characterize Sgp profiles of HIV glycoproteins under acute and chronic infection. Incorporation rate was found to be of higher level for the infected cells compared to uninfected, at the same time the Sgp patterns of HIV-1 of CSs and SNs were similar independently of the kind of infection (10) .
Further we compared ST-activity in CSs of acutely HIV-1-infected MT-2 cells and uninfected MT-2 cells ( Table 2) . As seen, there was a statistically significant difference between ST activity in CS of MT-2/HIV-1 compared to CS of MT-2. This corresponds well to our earlier findings detecting higher sialylation rate of MT-2/HIV-1 CSs compared to uninfected cells (10) .
It has been found higher ST-activity in SNs of MT-2/HIV-1 cells compared to SNs of uninfected ones. The results are presented as means ± S.E.M. (536 ± 52 and 361 ± 34 resp.) expressed on Fig. 4 .
It is of special interest to emphasize that in both kinds of infection the results obtained demonstrated much lower activity of the soluble form (SNs) of ST compared to the membrane linked one (CSs). Similarly, in the previous study the incorporation rate of the precursor of SA biosynthesis in SNs was lower than that in CSs of both acutely and chronically infected cells (10) .
Detection of specific pI peaks of Sgps of HIV-infected cells after preparative isoelectrofocusing demonstrated structural differences in localization and distribution of the terminal SA moieties (10) . A lot of authors studying distribution of SAs in Sialyl Lewis (Le X ) and Sialyl Le Y sequences associated to oncogenic and metastatic capacities of transformed cells, underlined the importance of specifity of sialylation process (12, 18, 5, 2, 9) . We intend to study further this specificity in experi- mental (acute and chronic) HIV-infection, as well as with HIV clinical isolates. Knowledge of structure of oligosaccharide chain of fetuin and the respective application of asialofetuin as an acceptor provides an opportunity for detection of either α2-3 or α2-6 linked ST (20) . One could assume that just the specific Sgps of HIV-1 in H9/HTLV III B and MT-2/HIV-1 cells were sialylated at higher level. This seems not valid for the peaks representing much lower sialylation rate accompanied with lack of RT-activity (10) . This assumption fits well to the viral specificity of sialylation.
In this study, transfer rates (expressed as pmolSA/1x10 6 cells/hr) of 14C-NANA were practically identical for CSs of chronically and acutely infected cells (although statistically significant difference between ST activities expressed as nmolesSA/mg protein/hr and 14C-NANA in-corporation was found , not shown). It is interesting to mark that to reach ST activity similar to that of acutely infected cells, the chronically infected ones needed 2,3x more nmoles SA , resp. higher incorporation ( Table 1, Table 2 ). We believe that a special study of the shape of saturation curves and the kinetics of the enzyme activity of infected and uninfected cells would provide an explanation to this difference. Earlier, Chelibonova-Lorer H. et al., (1989) found two times higher levels for both -the membrane-linked and soluble ST in Mc-29 induced transplantable hepatoma in chickens compared to normal liver tissue. Increased ST has also been reported in cells infected with other oncogenic viruses -as polyoma, mouse sarcoma virus (MSV) and Rous sarcoma virus (RSV) (13) . Here, we confirm also elevated (although not identical) ST activity in CSs of acutely and chronically HIV-infected cells.
Conclusions
In the current paper we report for the first time ST activity in human cells acutely and chronically infected with HIV-1 in cell culture. ST activity measured in the CSs and SNs of infected cells was about two times higher than those in uninfected ones. ST activity in CSs (membrane-linked forms) was always higher than that in SNs (soluble forms). This fact fits well to the assumption of virus specific sialylation found by us earlier when a direct radioactive precursor of biosynthesis of SAs as terminal moieties for Sgps of HIV-1 was used (10) .
